Home LiteratureArticle Details
PMID: 20101232 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

ERalpha signaling through slug regulates E-cadherin and EMT.

Oncogene ·Vol. 29 ·No. 10 ·2010-03-11 ·Pages 1451-62

Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, Barsky SH

Abstract

The ERalpha signaling pathway is one of the most important and most studied pathways in human breast cancer, yet numerous questions still exist such as how hormonally responsive cancers progress to a more aggressive and hormonally independent phenotype. We have noted that human breast cancers exhibit a strong direct correlation between ERalpha and E-cadherin expression by immunohistochemistry, suggesting that ERalpha signaling might regulate E-cadherin and implying that this regulation might influence epithelial-mesenchymal transition (EMT) and tumor progression. To investigate this hypothesis and the mechanisms behind it, we studied the effects of ERalpha signaling in ERalpha-transfected ERalpha-negative breast carcinoma cell lines, the MDA-MB-468 and the MDA-MB-231 and the effects of ERalpha knockdown in naturally expressing ERalpha-positive lines, MCF-7 and T47D. When ERalpha was overexpressed in the ERalpha-negative lines, 17beta-estradiol (E2) decreased slug and increased E-cadherin. Clones maximally exhibiting these changes grew more in clumps and became less invasive in Matrigel. When ERalpha was knocked down in the ERalpha-positive lines, slug increased, E-cadherin decreased, cells became spindly and exhibited increased Matrigel invasion. ERalpha signaling decreased slug expression by two different mechanisms: directly, by repression of slug transcription by the formation of a corepressor complex of ligand-activated ERalpha, HDAC inhibitor (HDAC1), and nuclear receptor corepressor (N-CoR) that bound the slug promoter in three half-site estrogen response elements (EREs); indirectly by phosphorylation and inactivation of GSK-3beta through phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt). The GSK-3beta inactivation, in turn, repressed slug expression and increased E-cadherin. In human breast cancer cases, there was a strong inverse correlation between slug and ERalpha and E-cadherin immunoreactivity. Our findings indicate that ERalpha signaling through slug regulates E-cadherin and EMT.

MeSH Terms
Blotting, Western Breast Neoplasms/genetics,metabolism,pathology Cadherins/genetics,metabolism Cell Line, Tumor Epithelium/metabolism,pathology Estradiol/pharmacology Estrogen Receptor alpha/genetics,metabolism Female Gene Expression Regulation, Neoplastic/drug effects Glycogen Synthase Kinase 3/metabolism Glycogen Synthase Kinase 3 beta Histone Deacetylase Inhibitors/pharmacology Humans Immunohistochemistry Mesoderm/metabolism,pathology Phosphatidylinositol 3-Kinases/metabolism Proto-Oncogene Proteins c-akt/metabolism RNA Interference Reverse Transcriptase Polymerase Chain Reaction Signal Transduction/drug effects Snail Family Transcription Factors Transcription Factors/genetics,metabolism
Chemicals
Cadherins Estrogen Receptor alpha Histone Deacetylase Inhibitors SNAI1 protein, human Snail Family Transcription Factors Transcription Factors Estradiol Phosphatidylinositol 3-Kinases GSK3B protein, human Glycogen Synthase Kinase 3 beta Proto-Oncogene Proteins c-akt Glycogen Synthase Kinase 3
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Ye Y
Department of Pathology, University of Nevada School of Medicine, Reno, NV 89557-0350, USA.
Xiao Y
Wang W
Yearsley K
Gao J X
Shetuni B
Barsky S H
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
1476-5594
Published
2010-03-11
Epub
2010-00-18
Pages
1451-62
Language
English
Region
England
NLM ID
8711562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com